We've been told before by the BOD that they will look at non dilutive funding.
It's no secret that at some point the company will need money. They might get this by a massive license deal, the company might be sold, they might get a gift from a generous donor.
no idea, is it because something happened at asco, is it because they have permission to run p1a alongside p1b now, is it to buy another diagnostic company, is it just tw bull****.